Original Post The genes in your body’s cells play a key role in your health. Indeed, a defective gene or genes can make you sick. Recognizing this, scientists have worked for decades on ways to modify genes or replace faulty genes with healthy ones to treat, cure, or prevent a disease or medical condition. This…
Read MoreOriginal Post Summary Company Announcement Date: July 25, 2022 FDA Publish Date: July 26, 2022 Product Type: Drugs Reason for Announcement: Potential Gluconacetobacter liquefaciens contamination Company Name: Vi-Jon, LLC Brand Name: Multiple Brands Product Description: Magnesium Citrate Saline Laxative Oral Solution Company Announcement FOR IMMEDIATE RELEASE – July 25, 2022 – Smyrna, TN, Vi-Jon, LLC is expanding its voluntary…
Read MoreOriginal Post Summary Company Announcement Date: July 21, 2022 FDA Publish Date: July 21, 2022 Product Type: Drugs Reason for Announcement: Products stored outside of temperature requirements Company Name: Family Dollar Brand Name: Multiple brands Product Description: Multiple OTC Medical Products Company Announcement Family Dollar is initiating a voluntary retail level product recall of certain…
Read MoreOriginal Post The SARS-CoV-2 virus has mutated over time, resulting in genetic variation in the population of circulating viral strains, also called lineages. This genetic variation may impact the virus’s properties such as transmission (for example, it may spread more easily) or the severity of symptoms on infected individuals (for example, it may cause more…
Read MoreDo Not Use Ultraviolet (UV) Wands That Give Off Unsafe Levels of Radiation: FDA Safety Communication
Original Post Date Issued: July 20, 2022 The U.S. Food and Drug Administration (FDA) is warning consumers about the potential risk of injury associated with the use of certain brands of ultraviolet (UV) wands. Do not use these UV wands for disinfection because they may expose the user or any nearby person to unsafe levels…
Read MoreOriginal Post Date Issued: July 15, 2022 The U.S. Food and Drug Administration (FDA) is advising people to use swab samples taken directly from a lesion (rash or growth) when testing for the monkeypox virus. The FDA is not aware of clinical data supporting the use of other sample types, such as blood or saliva,…
Read MoreOriginal Post For Immediate Release: July 13, 2022 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older. “Authorizing an additional COVID-19 vaccine expands…
Read MoreOriginal Post For Immediate Release:July 14, 2022 Today, the U.S. Food and Drug Administration announced the availability of educational resources for parents and caregivers with questions about using the hundreds of millions of bottles worth of imported infant formula headed to the U.S. “Parents and caregivers should have confidence that our collective work with federal partners, manufacturers…
Read MoreOriginal Post For Immediate Release: July 08, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities. Company (Product Origin): Care A2+ (Australia) Product(s): Care A2+ 0-12 Months Infant Formula Type of Formula: General…
Read MoreOriginal Post New Prescribing Authority Could Improve Access for Some Patients at High Risk for Severe COVID-19 For Immediate Release: July 06, 2022 Today, the U.S. Food and Drug Administration revised the Emergency Use Authorization(EUA) for Paxlovid (nirmatrelvir and ritonavir), to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate…
Read More